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Abstract
An increase in beta-band activity has been observed in the basal ganglia-thalamocortical
(BGTC) network of Parkinson’s patients, however, when beta-band oscillations change relative
to visible PD motor symptoms and how it is changing across multiple nodes in the BGTC
network with the increasing severity of PD remain unclear. Using simultaneously recorded local
field potential activity from the BGTC network in a rhesus macaque, I observed changes in the
low beta band (8-20 Hz) activity across multiple nodes in the network at the very mild stage of
PD, where only a little or no motor signs were presented. A progressive increase in the high-beta
band (21-35 Hz) in the STN and GP was observed corresponding with the increase in
parkinsonian severity. Thus, results show that changes in low and high beta bands can be distinct
from each other with the progression of parkinsonism. I hypothesize that these changes disrupt
the motor function of the BGTC network, leading to the motor symptoms found in PD.
Introduction
Parkinson’s disease (PD) is a progressive neurological disorder that consists of
debilitating motor symptoms, such as bradykinesia, rigidity, and tremor.1 These symptoms can be
linked to a decrease in dopaminergic input to the basal ganglia (BG) causing changes in the basal
ganglia thalamocortical (BGTC) loop, a neural network involved in many movement disorders.2
Previous studies have found an increase in beta band oscillatory activity in the BGTC network
that is thought to play a role in the expression of the motor symptoms of PD.3
Beta band oscillations (8-35 Hz) are associated with muscle contractions in the motor
cortex, known to increase with motor control and decrease with changes in movement.4 This
excessive beta oscillation synchronization has been hypothesized to be a pathophysiological
marker of PD, which may disrupt communication between brain areas during movement.5 The
reduction of this activity with deep brain stimulation (DBS), together with the improvement of
bradykinesia and rigidity, also supported the pathophysiological role of beta activity in PD.6,7 It is
currently unknown whether changes in beta activity precede or coincide with the onset of visible
motor symptoms and how it is changing with the progression of PD in multiple nodes of the
BGTC network. Determining the timing of oscillatory changes in both cortical and subcortical
areas in the BGTC network allows for the identification of potential biomarkers related to
different stages of PD, which would provide information to improve DBS and further determine
its mechanisms of action.
I begin to address this gap in knowledge using a progressive nonhuman primate model of
PD and prior simultaneous recordings of neuronal activity across multiple nodes in the BGTC
network, including the motor cortex (M1), subthalamic nucleus (STN), and globus pallidus (GP).
This approach provides a novel way to analyze the temporal changes of beta oscillations in
multiple nodes in PD.
Methods
All procedures were approved by the University of Minnesota Institutional Animal Care
and Use Committee and complied with US Public Health Service policies on human care and use
of laboratory animals. A female rhesus macaque was rendered parkinsonian by systemic weekly
or biweekly intramuscular injections (0.3-0.8 mg/kg) of
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Behavioral assessment: The severity of PD symptoms was assessed using the modified Unified
Parkinsonian Disease Rating Scale (mUPDRS), rating axial motor symptoms (gait, posture,
balance, and defense reaction) and appendicular motor symptoms (rigidity, bradykinesia,
akinesia, and tremor). Scores were given on a 0-3 scale (0 as normal, 3 as severe) with the
highest score being 39. 4 parkinsonian states were determined by assessing severity of
parkinsonian symptoms through mUDPRS scores; 0-3 (State 1), 4-6 (State 2), 7-10.5 (State 3),
>10.5 (State 4).
Neurophysiological recordings: Local field potential (LFP) signals were collected through 2
scaled-down 8-channel DBS leads (NuMed) implanted in STN and GP, respectively and a Utah
96-channel microelectrode array (1.5mm depth, Blackrock) implanted in the arm area of M1.
Recordings were performed once or twice after each MPTP injection with the animal in a resting,
awake state, determined by eye and contralateral arm motion captures.
Data processing: All analysis was performed using MATLAB scripts. Each session of LFP data
was filtered to 3kHz and segmented into 12s duration segments. Only resting-awake data was
kept, differentiated from sleeping states through eye monitoring. The power spectral density
(PSD) was used to identify changes in power, both in low-beta (8-20 Hz) and high-beta (21-35
Hz), and in different brain structures across states, as calculated for each segment in MATLAB.
In order to compare beta oscillations, I normalized each segment using z-scores and utilized
these scores for analysis.
Results
Changes in low beta-band oscillations throughout the network. There is a progressive increase in
low beta-band power in the STN and GP while there was overall decrease in M1 (Fig 1).
Figure 1: Changes in power with increasing parkinsonism severity. Low (8-20 Hz) and high
(21-35 Hz) for each site by first three injections then by state. Wilcoxon one-way tests; *p<0.01,
**p<0.05.
Distinct changes in low and high beta-band oscillations. There is a progressive increase in STN
and GP high beta activity and no change in M1 (Fig 1). This difference suggests the possibility
of distinct roles of both low and high beta power changes in the development of parkinson’s
disease.
Figure 2: Changes in parkinsonian severity determined by mUPDRS with scores.
Changes in beta-band oscillatory activity precede the onset of parkinsonism motor symptoms.
Significant changes across in low-beta band activity the network occurred as motor symptoms
progressed. There is an increase in STN and GP power with mUPDRS and there are significant
changes early in parkinsonism (Fig 1,2). These changes are important in identifying beta-band
oscillations as a biomarker for PD.
Conclusion
These findings support a link between changes in beta-band oscillations in the BGTC
network and motor symptoms of PD, with the independent changes in low and high beta bands.
These results also imply an impact of beta-band oscillation disruption on the ability of the BGTC
network to encode sensory-motor information, thus inducing PD symptoms. Finally, these results
emphasize the importance of utilizing a holistic approach in analyzing temporal changes of beta
oscillations to better identify biomarkers for potential symptom characterization.
Future analysis of these results in another animal is important to understanding if these
changes are consistent in all patients. Further future research in oscillatory changes with specific
behavioral/movement epochs and coherence between the subcortical and cortical regions are also
important steps in understanding changes in beta band oscillations as a biomarker for PD.
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